COVID-19 severity linked to differences in DNA
UK researchers have identified 16 genetic variants in people who develop severe disease reveals paper in Nature
Researchers have pinpointed 16 new genetic variants in people who developed severe COVID-19 that may help explain why some patients develop serious symptoms.
The results suggest that people with severe disease have genes that predispose them to one of two problems: a failure to limit replication of SARS-CoV-2 or excessive inflammation and blood clotting.
The authors said their findings, published in Nature, could help prioritise likely treatments for COVID-19.
Eventually, the information could even help predict which patients were likely to become severely ill, they said.
